SYEDA AKHTAR: Open Payments
NPI 1134215155 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 50 payments from 10 companies in 2025. Trend: 2023 $105 · 2024 $165 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $204 |
| Janssen Pharmaceuticals, Inc | 6 | $110 |
| Neurocrine BioSciences, Inc. | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Alkermes, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
Products named: VRAYLAR, INGREZZA, COBENFY, SPRAVATO, ARISTADA, INVEGA SUSTENNA, FANAPT, Auvelity.
Industry payments across NJ — which companies pay providers there.
